AI reads your ECG to catch silent heart danger before surgery
NCT ID NCT07344207
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an artificial intelligence system can analyze standard heart tracings (ECGs) to detect pulmonary hypertension—a serious but often unnoticed condition—before surgery. About 1,380 adults scheduled for non-cardiac surgery will be randomly assigned to get the AI screening or usual care. The goal is to see if the AI finds more cases and helps reduce surgical complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Artificial intelligence-enabled electrocardiography system
- What this could lead to
- If it works, this could become a routine, low-cost way to catch dangerous heart conditions before surgery, potentially preventing complications.
- What could go wrong
- This is an early-stage trial with no phase assigned, so the AI may not be accurate enough in real-world use. It also only looks at detection, not treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COMPLICATIONS (CARDIOPULMONARY) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Taipei Veterans General Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study to reveal best way to ventilate patients on the move
- Exercise before ovarian cancer surgery may reduce frailty and boost recovery
- Eye test could spot kids at risk for opioid breathing trouble
- Short Pre-Surgery exercise test may spot hidden risks
- AI to uncover hidden social risks for brain aneurysm patients
- Rare cancer study seeks clues in blood and lab models